Burden of Shigella among children with diarrhea in the Americas: A systematic review and meta-analysis

Maya Lubeck-Schricker1, Andrea C Rivas-Nieto1, Jennifer Rosauer1

  • 1Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.

PubMed

Insights

Shigella bacteria significantly contribute to childhood diarrhea in the Americas. Standardized surveillance is crucial for developing effective Shigella vaccines tailored to regional needs.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Vaccinology

Background:

  • Shigella is a major global cause of diarrheal disease, with a significant burden observed in the Americas.
  • Pediatric Shigella vaccines are in clinical development, necessitating an understanding of regional disease burden for policymakers.

Purpose of the Study:

  • To systematically review and meta-analyze the burden of Shigella diarrhea in children under 72 months in the Americas (excluding U.S., Canada, Greenland).
  • To inform potential Shigella vaccine implementation strategies in the region.

Main Methods:

  • Systematic review and random effects meta-analyses of published and pre-print articles from 2000-2024.
  • Searched six databases for studies on Shigella prevalence, incidence, and attributable fraction in children under 72 months.
  • Included 34 studies from 14 countries, analyzing data based on detection methods (culture, PCR/qPCR) and age groups.

Main Results:

  • Pooled prevalence of Shigella among diarrhea cases was 3.1% (culture) and 16.5% (PCR/qPCR).
  • Prevalence varied by age, with higher rates in children ≥12 months (4.6%) compared to <12 months (1.0%) using culture methods.
  • Significant heterogeneity was observed across studies, with limited geographic representation and variable age-specific data.

Conclusions:

  • Shigella is an important cause of diarrhea in the Americas, though data reporting is inconsistent.
  • Gaps in data include limited geographic coverage and variable age-specific estimates.
  • Standardized Shigella surveillance in the Americas is recommended to support vaccine development and introduction decisions.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
203
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
411
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
117